Skip to main content
Top
Published in: BMC Infectious Diseases 1/2007

Open Access 01-12-2007 | Research article

Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: A questionnaire study

Authors: Morris Gordon, Hannah Roberts, Egware Odeka

Published in: BMC Infectious Diseases | Issue 1/2007

Login to get access

Abstract

Background

Universal BCG vaccination in the UK ended in 2005. The new vaccination policy instead offers a number of different forms of selective vaccination to newborns based on risk of acquiring TB. We set out to assess the attitudes and knowledge of both parents and professionals to the new policy for neonatal BCG vaccination.

Methods

A short questionnaire was designed, made up of demographic and attitude questions, as well as very basic knowledge questions. The researchers handed out the questionnaire to all parents and professionals in the antenatal and postnatal areas, as well as the paediatric and neonatal units during a 6-week period. The site was the Royal Oldham hospital, a district general hospital with 3250 deliveries per year and multi-ethnic in its population mix.

Results

A total of 253 completed questionnaires were collected. The ethnic origin of responders was 50.6% White British, 18.2% Bangladeshi, 8.7% Indian, 4% White/Asian, the remaining 18.5% of other origins. 71.5% of responders said they had heard of BCG vaccine. When asked if they knew the new policy for its use, 33.2% answered yes. 24.5% gave the most accurate response when asked who now receives BCG.

Conclusion

We have found that amongst parents and professionals alike there is a lack of knowledge of the new policy. This has lead to confusion and as knowledge amongst the professionals who identify neonates for vaccination is low, uptake may be sub-optimal. We suggest that units investigate the issue and ensure that the new policy is understood and implemented correctly.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Pharoah PD, Watson JM, Sen S: Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?. Public Health. 1996, 110: 179-83. 10.1016/S0033-3506(96)80073-4.CrossRefPubMed Pharoah PD, Watson JM, Sen S: Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?. Public Health. 1996, 110: 179-83. 10.1016/S0033-3506(96)80073-4.CrossRefPubMed
4.
go back to reference Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV: The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995, 96: 29-35.PubMed Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV: The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995, 96: 29-35.PubMed
7.
go back to reference Teo SSS, Shingadia DV: Does BCG have a role in tuberculosis control and prevention in the United Kingdom?. Arch Dis Child. 2006, 91: 529-531. 10.1136/adc.2005.085043.CrossRefPubMedPubMedCentral Teo SSS, Shingadia DV: Does BCG have a role in tuberculosis control and prevention in the United Kingdom?. Arch Dis Child. 2006, 91: 529-531. 10.1136/adc.2005.085043.CrossRefPubMedPubMedCentral
10.
go back to reference Srinivasan R, Stevens P: Selective neonatal BCG vaccination: Specialist clinics are an alternative. Acta Paediatrica. 2005, 94: 634-637. 10.1080/08035250510025833.CrossRefPubMed Srinivasan R, Stevens P: Selective neonatal BCG vaccination: Specialist clinics are an alternative. Acta Paediatrica. 2005, 94: 634-637. 10.1080/08035250510025833.CrossRefPubMed
12.
go back to reference Mennon L, Srinivasan R, Alfaham M: Selective neonatal BCG immunisation in a multiethnic community: poor uptake among white British infants. Communicable disease and public health. 2004, 7 (4): 388- Mennon L, Srinivasan R, Alfaham M: Selective neonatal BCG immunisation in a multiethnic community: poor uptake among white British infants. Communicable disease and public health. 2004, 7 (4): 388-
13.
go back to reference Tuberculosis: Improvements to BCG immunisation programme, Department of Health Press Release number 2005/0239. London. 2005 Tuberculosis: Improvements to BCG immunisation programme, Department of Health Press Release number 2005/0239. London. 2005
14.
go back to reference Annex 2 Global data for TB burden. 2004, World Health Organization Annex 2 Global data for TB burden. 2004, World Health Organization
Metadata
Title
Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: A questionnaire study
Authors
Morris Gordon
Hannah Roberts
Egware Odeka
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2007
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-7-82

Other articles of this Issue 1/2007

BMC Infectious Diseases 1/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.